August 2000

Long-term Efficacy of Tacrolimus Ointment for Recalcitrant Facial Erythema Resistant to Topical Corticosteroids in Adult Patients With Atopic Dermatitis

Author Affiliations

Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000

Arch Dermatol. 2000;136(8):1062-1063. doi:

Recalcitrant facial erythema often occurs in adults with atopic dermatitis and resists common therapies, including topical corticosteroids.1 Recently, several authors have reported that short-term use of tacrolimus (FK506) ointment, a newly developed immunosuppressant drug, shows excellent results with recalcitrant facial erythema.25 In the present study, we analyzed the effects of long-term applications of topical tacrolimus on red face conditions.

First Page Preview View Large
First page PDF preview
First page PDF preview